Ireland
# |
Name |
Net Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
21.39%
|
Dec. 31, 2023 | USD 31.53 | -1.19% |
|
Ireland |
|
2 |
13.00%
|
Oct. 25, 2024 | USD 90.82 | -0.95% |
|
Ireland |
|
3 |
10.82%
|
Dec. 31, 2023 | USD 124.37 | -0.54% |
|
Ireland |
|
4 |
8.66%
|
Dec. 31, 2024 | USD 225.44 | 2.09% |
|
Ireland |
|
5 |
7.54%
|
Dec. 31, 2023 | USD 199.08 | -1.31% |
|
Ireland |
|
6 |
1.76%
|
Dec. 31, 2023 | USD 2.56 | 3.17% |
|
Ireland |
|
7 |
-5.32%
|
Dec. 31, 2023 | USD 70.72 | 0.21% |
|
Ireland |
|
8 |
-160.91%
|
Dec. 31, 2023 | USD 14.23 | -3.20% |
|
Ireland |
|
9 |
-573.17%
|
Dec. 31, 2023 | USD 7.90 | 2.73% |
|
Ireland |
The Healthcare company in Ireland with the highest Net Income Margin is Alkermes plc (NasdaqGS: ALKS) at 21.39%.
The Healthcare company in Ireland with the lowest Net Income Margin is Avadel Pharmaceuticals plc (NasdaqGM: AVDL) at -573.17%.
The top 10 Healthcare companies in Ireland by Net Income Margin are Alkermes plc, Medtronic plc, Jazz Pharmaceuticals plc, STERIS plc, ICON Public Limited Company, Uniphar plc, Cosmo Pharmaceuticals N.V., Prothena Corporation plc and Avadel Pharmaceuticals plc.
The bottom 10 Healthcare companies in Ireland by Net Income Margin are Avadel Pharmaceuticals plc, Prothena Corporation plc, Cosmo Pharmaceuticals N.V., Uniphar plc, ICON Public Limited Company, STERIS plc, Jazz Pharmaceuticals plc, Medtronic plc and Alkermes plc.